investors intelligence
Generating first rate investment advice since 1947
  Analysis: Standard   Archive
Featured Article 
October 2005

From The Chart Room: Good And Bad Climaxes
John Dobosz,, 12:00 PM ET 

YORK - The Dow is still 4.3% below its March high of 11,027, while the S&P 500 Index and Nasdaq both hit four-year highs in the past two weeks but have fallen back 1.9% and 3.3%, respectively. The S&P hit a high of 1,245.86 on Aug. 3, and on the same day the Nasdaq got up to 2,219.91. Thereís nothing wrong with hitting new multiyear highs, but when a stock or index follows up on a new high by closing lower for the week, thatís a very bearish sign.

Michael Burke, editor of Investors Intelligence, has a term for what the Nasdaq and S&P 500 did two weeks ago: He calls it a buying climax. "Buying climaxes occur when a stock makes a 12-month high but closes the week with a loss," says Burke. "They are a sign of distribution and indicate that stocks are moving from strong hands to weak ones."

Investors Intelligence reported a spike in the number of buying climaxes over the past several weeks, with 530 occurring two weeks ago and 71 last week. The upturn in buying climaxes and their occurrence in

It is very possible that the summer rally has ended and corrective action is near," says Burke, adding, "September is the only month with a historical record of losses, and we have also seen a number of good-sized drops in October. Short-term indicators have moved to sell signals."

The opposite of a buying climax is a selling climax, which is a bullish sign that a stock has bottomed. ĒOur work shows that sellers into buying climaxes and buyers into selling climaxes are right about 80% of the time after four months," Burke says. A glance at the chart below shows that spikes in selling climaxes tend to precede market rebounds, while a sharp rise in buying climaxes precedes market drops.

So while the momentum in the broad market appears to be slipping, there may be some opportunities among last weekís 27 selling climaxes identified by Investors Intelligence. We selected from two of the better-performing indices, the S&P MidCap 400 and the S&P SmallCap 600.

Among mid-caps, laboratory testing company Beckman Coulter (nyse: BEC ) is up more than 3.5% from its 52-week low last Aug. 15 of $52.25. Also, digital rights management company Macrovision (nasdaq: MVSN) has fallen nearly 20% in August, but so far has successfully bounced off of a $17.51 Aug. 11 low.

Ryanís Restaurant Group (nasdaq: RYAN) is a small-cap that bottomed out on Aug. 9 at $12.13 and has so far not breached the low. Another small-cap, Daktronics (nasdaq: DAKT), which makes electronic scoreboards and large signs, hit a 52-week low of $19.20 on Aug. 8 and is up 6.5% off of the low. On Aug. 10, Richmond, Va., plastic and aluminum supplier Tredegar (nyse: TG) traded as low as $12.92, but within four days had risen 6.1% to $13.72.


Selling Climaxes for Aug. 15, 2005

Beckman Coulter (nyse: BEC - news - people )
Daktronics (nasdaq: DAKT - news - people )
Macrovision (nasdaq: MVSN - news - people )
Ryanís Restaurant Group (nasdaq: RYAN - news - people )
Tredegar (nyse: TG - news - people )

US Sentiment holds the key
The Advisors Sentiment Survey continues to provide advance warning of major market turning points.  
The analysis and data regularly feature in the international financial press as a key indicator of market reversion.
Examples of these articles can be found on Barrons, NY Times, and Investor's Business Daily.
Want to know more?  Click here  - and you can subscribe for just $335 annually.

Historic Advisors’ Sentiment data since 1963 is also available; please contact us for further details.

"This is an exceptional service and should be in every traders toolbox.
Thank you for the great service!" C.C.
Free Research
To receive occasional free research material please follow the links below to sign up.
Existing users: Click here
Others Click here to subscribe now.
Our Services
Investors Intelligence is a leading independent provider of research and technical analysis of stocks, currencies, commodities and financial futures.

Read more, and trial our services below: